These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31588675)

  • 1. Population-based study evaluating and predicting the probability of death resulting from thyroid cancer among patients with papillary thyroid microcarcinoma.
    Wang K; Xu J; Li S; Liu S; Zhang L
    Cancer Med; 2019 Nov; 8(16):6977-6985. PubMed ID: 31588675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer.
    Yang L; Shen W; Sakamoto N
    J Clin Oncol; 2013 Feb; 31(4):468-74. PubMed ID: 23270002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of competing risk model in the prognostic prediction study of patients with follicular thyroid carcinoma.
    Wang Z; Mo C; Chen L; Kong L; Wu K; Zhu Y; Chen X
    Updates Surg; 2022 Apr; 74(2):735-746. PubMed ID: 34086182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a nomogram for preoperative prediction of cervical lymph node involvement in thyroid microcarcinoma.
    Lu S; Zhao R; Ni Y; Ding J; Qiu F; Peng Y; Pan G; Wu F; Zhang Y; Shi J; Zhou T; Luo D
    Aging (Albany NY); 2020 Mar; 12(6):4896-4906. PubMed ID: 32170046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Competing-Risks Nomogram in Patients with Metastatic Pancreatic Duct Adenocarcinoma.
    Lu Y; Zhou Y; Cao Y; Shi Z; Meng Q
    Med Sci Monit; 2019 May; 25():3683-3691. PubMed ID: 31102397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A competing risk nomogram predicting cause-specific mortality in patients with lung adenosquamous carcinoma.
    Wu X; Yu W; Petersen RH; Sheng H; Wang Y; Lv W; Hu J
    BMC Cancer; 2020 May; 20(1):429. PubMed ID: 32416716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomogram for predicting central lymph node metastasis in papillary thyroid microcarcinoma: A retrospective cohort study of 8668 patients.
    Wang Y; Guan Q; Xiang J
    Int J Surg; 2018 Jul; 55():98-102. PubMed ID: 29803769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.
    Zhou H; Zhang Y; Qiu Z; Chen G; Hong S; Chen X; Zhang Z; Huang Y; Zhang L
    Clin Lung Cancer; 2018 Mar; 19(2):e195-e203. PubMed ID: 29153966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model to Predict Cause-Specific Mortality in Patients with Head and Neck Adenoid Cystic Carcinoma: A Competing Risk Analysis.
    Shen W; Sakamoto N; Yang L
    Ann Surg Oncol; 2017 Aug; 24(8):2129-2136. PubMed ID: 28424937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomograms for Estimating Cause-Specific Death Rates of Patients With Inflammatory Breast Cancer: A Competing-Risks Analysis.
    Xu F; Yang J; Han D; Huang Q; Li C; Zheng S; Wang H; Lyu J
    Technol Cancer Res Treat; 2021; 20():15330338211016371. PubMed ID: 34013802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
    Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
    J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomograms Based on Serum
    Zhang Z; Cao Z; Liu R; Li Z; Wu J; Liu X; Wu M; Xu X; Liu Z
    Curr Oncol; 2022 Aug; 29(9):6018-6034. PubMed ID: 36135043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: a population-based analysis.
    Shen W; Sakamoto N; Yang L
    BMC Cancer; 2016 Jul; 16():413. PubMed ID: 27389173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competing-Risks Model for Predicting the Postoperative Prognosis of Patients with Papillary Thyroid Adenocarcinoma Based on The Surveillance, Epidemiology, and End Results (SEER) Database.
    Bian F; Li C; Han D; Xu F; Lyu J
    Med Sci Monit; 2020 Jul; 26():e924045. PubMed ID: 32710734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retrospective comparison of screening criteria for active surveillance for papillary thyroid microcarcinoma].
    Qian K; Sun TQ; Guo K; Zheng XK; Li DS; Wei WW; Wu Y; Ji QH; Wang ZY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):430-434. PubMed ID: 28635215
    [No Abstract]   [Full Text] [Related]  

  • 16. Competing-risks nomograms for predicting cause-specific mortality in parotid-gland carcinoma: A population-based analysis.
    Xu F; Feng X; Zhao F; Huang Q; Han D; Li C; Zheng S; Lyu J
    Cancer Med; 2021 Jun; 10(11):3756-3769. PubMed ID: 33960711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients.
    Vasileiadis I; Karatzas T; Vasileiadis D; Kapetanakis S; Charitoudis G; Karakostas E; Kouraklis G
    Head Neck; 2014 Apr; 36(4):564-70. PubMed ID: 23780707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Pathologic Predictors of Lymph Node Metastasis and Recurrence in Papillary Thyroid Microcarcinoma.
    Siddiqui S; White MG; Antic T; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
    Thyroid; 2016 Jun; 26(6):807-15. PubMed ID: 27117842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival with Follicular and Hurthle Cell Microcarcinoma Compared to Papillary Thyroid Microcarcinoma: A Population Study of 84,532 Patients.
    Khokar AM; Holoubek SA; Kuchta KM; Winchester DJ; Prinz RA; Moo-Young TA
    World J Surg; 2020 Feb; 44(2):469-478. PubMed ID: 31863140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram model for predicting cause-specific mortality in patients with stage I small-cell lung cancer: a competing risk analysis.
    Li J; Zheng Q; Zhao X; Zhao J; An T; Wu M; Wang Y; Zhuo M; Zhong J; Yang X; Jia B; Chen H; Dong Z; Wang J; Chi Y; Zhai X; Wang Z
    BMC Cancer; 2020 Aug; 20(1):793. PubMed ID: 32838776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.